ASB · Associated Banc-Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | $329.73M | $321.75M | $322.84M | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $12.21M | - | - | - | $13.98M | - | - | - | $12.35M | - |
| Operating Income | $152.88M | - | $154.29M | $139.63M | $121.09M | - | $108.14M | $102.88M | $101.19M | - |
| Interest Expense | $220.85M | - | $251.37M | $245.54M | $239.94M | - | $277.81M | $273.68M | $265.53M | - |
| Income Tax | $33.25M | - | $29.55M | $28.40M | $19.41M | - | $20.12M | ($12.69M) | $20.02M | - |
| Net Income | $119.64M | - | $124.73M | $111.23M | $101.69M | - | $88.02M | $115.57M | $81.17M | - |
| EPS - Basic | $0.70 | - | $0.73 | $0.65 | $0.60 | - | $0.56 | $0.75 | $0.52 | - |
| EPS - Diluted | $0.70 | - | $0.73 | $0.65 | $0.59 | - | $0.56 | $0.74 | $0.52 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.39B | $1.72B | $1.29B | $1.26B | $1.23B | $1.02B | $967.04M | $959.09M | $851.58M | $923.82M |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - | - | - | - | - |
| Total Assets | $45.59B | $45.20B | $44.46B | $43.99B | $43.31B | $43.02B | $42.21B | $41.62B | $41.14B | $41.02B |
| Current Liabilities | - | - | - | - | - | - | - | - | - | - |
| Long-term Debt | $592.63M | $1.01B | $594.07M | $593.53M | $591.38M | $1.44B | $844.34M | $536.11M | $536.05M | $1.74B |
| Total Liabilities | $40.60B | $40.23B | $39.59B | $39.21B | $38.62B | $38.42B | $37.80B | $37.38B | $36.97B | $36.84B |
| Stockholders' Equity | $5.00B | $4.98B | $4.87B | $4.78B | $4.69B | $4.61B | $4.41B | $4.24B | $4.17B | $4.17B |
| Retained Earnings | $3.30B | $3.23B | $3.13B | $3.05B | $2.92B | - | $3.12B | $3.07B | $2.99B | $2.95B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $135.87M | - | - | - | $98.17M | - | - | - | $154.50M | - |
| Investing Cash Flow | ($824.18M) | - | - | - | ($127.12M) | - | - | - | ($275.32M) | - |
| Financing Cash Flow | $354.27M | - | - | - | $241.81M | - | - | - | $48.58M | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | 32.8% | 32.0% | 31.3% | - |
| EBITDA margin | - | - | - | - | - | - | - | - | 35.2% | - |
| Net margin | - | - | - | - | - | - | 26.7% | 35.9% | 25.1% | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | 21.7% | - | 19.2% | 20.3% | 16.0% | - | 18.6% | -12.3% | 19.8% | - |
| Return on assets | 0.3% | - | 0.3% | 0.3% | 0.2% | - | 0.2% | 0.3% | 0.2% | - |
| Return on equity | 2.4% | - | 2.6% | 2.3% | 2.2% | - | 2.0% | 2.7% | 1.9% | - |
| Return on invested capital | 2.1% | - | 2.3% | 2.1% | 1.9% | - | 1.7% | 2.2% | 1.7% | - |
| Liquidity | ||||||||||
| Current ratio | - | - | - | - | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - | - | - | - | - |
| Leverage | ||||||||||
| Debt / Equity | 0.12 | 0.20 | 0.12 | 0.12 | 0.13 | 0.31 | 0.19 | 0.13 | 0.13 | 0.42 |
| Debt / Assets | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.03 | 0.02 | 0.01 | 0.01 | 0.04 |
| Debt / EBITDA | 3.59 | - | - | - | 4.38 | - | - | - | 4.72 | - |
| Interest coverage | 0.7x | - | 0.6x | 0.6x | 0.5x | - | 0.4x | 0.4x | 0.4x | - |
| Equity multiplier | 9.12 | 9.09 | 9.13 | 9.20 | 9.24 | 9.34 | 9.56 | 9.81 | 9.87 | 9.83 |
| Liabilities / Assets | 0.89 | 0.89 | 0.89 | 0.89 | 0.89 | 0.89 | 0.90 | 0.90 | 0.90 | 0.90 |
| Efficiency | ||||||||||
| Asset turnover | - | - | - | - | - | - | 0.01 | 0.01 | 0.01 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 36.9x | - | 35.2x | 37.5x | 38.2x | - | 38.5x | 28.6x | 41.4x | - |
| P / B | 0.9x | - | 0.9x | 0.8x | 0.8x | - | 0.7x | 0.8x | 0.8x | - |
| P / S | - | - | - | - | - | - | 9.9x | 9.9x | 10.1x | - |
| EV / EBITDA | 21.3x | - | - | - | 23.0x | - | - | - | 25.9x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | 2.8% | -0.5% | -3.9% | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | 7.5% | 8.3% | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | 1.4% | 0.8% | 1.0% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 26.3% | - | 42.7% | 35.7% | 19.7% | - | 5.3% | -7.0% | -22.6% | - |
| Net income growth (YoY) | 17.7% | - | 41.7% | -3.8% | 25.3% | - | 5.7% | 32.6% | -21.5% | - |
| EPS growth (YoY) | 18.6% | - | 30.4% | -12.2% | 13.5% | - | 5.7% | 32.1% | -21.2% | - |
| EPS CAGR (3y) | 2.0% | - | 5.6% | 5.1% | 7.9% | - | 0.0% | 9.7% | - | - |
| EPS CAGR (5y) | - | - | 22.9% | -7.1% | 16.9% | - | 2.7% | 8.6% | 0.8% | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 6.6% | 8.0% | 10.3% | 12.7% | 12.4% | 10.3% | 6.9% | 2.9% | 1.0% | 3.9% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2023-12-31.
Business segments
$1.10B totalCommunity Consumerand Business$841.13M · 76.3%
Corporateand Commercial Specialty$703.76M · 63.8%
Risk Managementand Shared Services($442.14M) · -40.1%
Peer comparison
Same SIC group: State Commercial Banks
Comparing ASSOCIATED BANC-CORP against the 5 most active filers in the same SIC group.
Dividends
$0.95/share trailing 12 months · +4.4% YoY
| Ex-date | Per share |
|---|---|
| Jun 1, 2026 | $0.2400 |
| Mar 2, 2026 | $0.2400 |
| Dec 1, 2025 | $0.2400 |
| Sep 2, 2025 | $0.2300 |
| Jun 2, 2025 | $0.2300 |
| Mar 3, 2025 | $0.2300 |
| Dec 2, 2024 | $0.2300 |
| Sep 3, 2024 | $0.2200 |
| Jun 3, 2024 | $0.2200 |
| Feb 29, 2024 | $0.2200 |
| Nov 30, 2023 | $0.2200 |
| Aug 31, 2023 | $0.2100 |
| May 31, 2023 | $0.2100 |
| Feb 28, 2023 | $0.2100 |
| Nov 30, 2022 | $0.2100 |
| Aug 31, 2022 | $0.2000 |
| May 31, 2022 | $0.2000 |
| Feb 28, 2022 | $0.2000 |
| Nov 30, 2021 | $0.2000 |
| Aug 31, 2021 | $0.2000 |
| May 28, 2021 | $0.1800 |
| Feb 26, 2021 | $0.1800 |
| Nov 30, 2020 | $0.1800 |
| Aug 31, 2020 | $0.1800 |